Cooley Achieves Top Marks in US, Global M&A and PE Rankings

New York – January 13, 2025 – Cooley’s global mergers and acquisitions and private equity practices were recognized based on their M&A and PE activity on year-end league tables from Bloomberg, Mergermarket and LSEG Data & Analytics.

The recognitions were based on Cooley’s role in advising on 300+ transactions globally announced in 2024, comprising more than $86.24 billion in deal volume for the year.

Cooley’s mergers and acquisitions and private equity practices continue to dominate in public and private transactions in the US and globally – despite the unsettled market.

Cooley’s top rankings include:

• Bloomberg, which ranked the firm #2 on its US M&A league table by deal count and #4 on its global M&A league table by deal count. Bloomberg also ranked Cooley #2 for US mid-market M&A by deal count, #3 for global mid-market M&A by deal count, and #2 for US and global private equity deals by deal count.*
• Mergermarket, which ranked the firm #5 on its US M&A league table by deal count and #6 on its global M&A league table by deal count, as well as #4 for US private equity buyouts, #4 for global private equity buyouts by deal count and #5 for US private equity exits by deal count.
• LSEG, which ranked the firm #7 on its US M&A league table for announced deals by deal count and #10 on its global M&A league table for completed deals by deal count.

In 2024, Cooley handled deals across a diverse range of industries while also maintaining its top position in technology and life sciences. The firm’s market-leading transactions including representations of:

• Poseida Therapeutics in its $1.5 billion acquisition by Roche
• Tempus AI in its $600 million agreement to acquire Ambry Genetics
• AuditBoard in its $3 billion acquisition by Hg
• Longboard Pharmaceuticals in its $2.6 billion acquisition by Lundbeck
• ProfoundBio in its $1.8 billion acquisition by Genmab
• Transact Campus in its $1.6 billion acquisition by Roper Technologies
• PetIQ in its $1.5 billion merger with Bansk Group
• Everbridge in its $1.8 billion acquisition by Thoma Bravo
• Tenable in its acquisition of Eureka Security
• Accel in connection with Squarespace’s $6.9 billion go-private transaction with Permira
• AGS in its $1.1 billion acquisition by Brightstar Capital
• Tenet Medicines in its acquisition by Eliem Therapeutics
• Amolyt Pharma in its $1.05 billion acquisition by AstraZeneca
• Sazerac in its acquisition of BuzzBallz

Since 2020, Cooley’s world-class transactional team has worked on 1,600+ M&A deals for an aggregate value of more than $735 billion – guiding top public and private companies, financial advisors and private equity sponsors in some of the market’s largest and most complex transactions. The mergers and acquisitions and private equity groups include 180+ practitioners in major business and technology centers worldwide, representing all categories of participants in transactions.

* Bloomberg has not published deal counts outside of its platform data set.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation.

Cooley has nearly 1,400 lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of more than 3,000 people.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.